Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy / Authors: Li, Pengxiang, author - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy ✖ Authors Li, Pengxiang, author ✖

1. High cost sharing and specialty drug initiation under Medicare Part D: a case study in patients with newly diagnosed chronic myeloid leukemia

Author(s):: Doshi, Jalpa A., author
Li, Pengxiang, author
Huo, Hairong, author
Pettit, Amy R., author
Kumar, Rishab, author
Weiss, Brendan M., author
Huntington, Scott F., author
Publication:: Philadelphia, PA : Leonard Davis Institute of Health Economics, 2016
Subject(s):: Cost Sharing
Drug Costs
Medicare Part D -- economics
Financing, Personal
Health Services Accessibility
Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
Protein Kinase Inhibitors -- economics
Protein Kinase Inhibitors -- therapeutic use
Protein-Tyrosine Kinases -- antagonists & inhibitors
Humans
United States